219 related articles for article (PubMed ID: 25784651)
1. p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia.
Yetil A; Anchang B; Gouw AM; Adam SJ; Zabuawala T; Parameswaran R; van Riggelen J; Plevritis S; Felsher DW
Oncotarget; 2015 Feb; 6(6):3563-77. PubMed ID: 25784651
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Bertwistle D; Sherr CJ
Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
[TBL] [Abstract][Full Text] [Related]
4. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
5. Control of cellular senescence by CPEB.
Groisman I; Ivshina M; Marin V; Kennedy NJ; Davis RJ; Richter JD
Genes Dev; 2006 Oct; 20(19):2701-12. PubMed ID: 17015432
[TBL] [Abstract][Full Text] [Related]
6. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.
Wu CH; van Riggelen J; Yetil A; Fan AC; Bachireddy P; Felsher DW
Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13028-33. PubMed ID: 17664422
[TBL] [Abstract][Full Text] [Related]
7. Loss of function tp53 mutations do not accelerate the onset of myc-induced T-cell acute lymphoblastic leukaemia in the zebrafish.
Gutierrez A; Feng H; Stevenson K; Neuberg DS; Calzada O; Zhou Y; Langenau DM; Look AT
Br J Haematol; 2014 Jul; 166(1):84-90. PubMed ID: 24690081
[TBL] [Abstract][Full Text] [Related]
8. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.
Carnero A; Hudson JD; Price CM; Beach DH
Nat Cell Biol; 2000 Mar; 2(3):148-55. PubMed ID: 10707085
[TBL] [Abstract][Full Text] [Related]
9. Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.
Giuriato S; Ryeom S; Fan AC; Bachireddy P; Lynch RC; Rioth MJ; van Riggelen J; Kopelman AM; Passegué E; Tang F; Folkman J; Felsher DW
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16266-71. PubMed ID: 17056717
[TBL] [Abstract][Full Text] [Related]
10. Dual inactivation of RB and p53 pathways in RAS-induced melanomas.
Bardeesy N; Bastian BC; Hezel A; Pinkel D; DePinho RA; Chin L
Mol Cell Biol; 2001 Mar; 21(6):2144-53. PubMed ID: 11238948
[TBL] [Abstract][Full Text] [Related]
11. Cellular Senescence in Mouse Hippocampus After Irradiation and the Role of p53 and p21.
Cheng Z; Zheng YZ; Li YQ; Wong CS
J Neuropathol Exp Neurol; 2017 Apr; 76(4):260-269. PubMed ID: 28340115
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene.
Lefebure M; Tothill RW; Kruse E; Hawkins ED; Shortt J; Matthews GM; Gregory GP; Martin BP; Kelly MJ; Todorovski I; Doyle MA; Lupat R; Li J; Schroeder J; Wall M; Craig S; Poortinga G; Cameron D; Bywater M; Kats L; Gearhart MD; Bardwell VJ; Dickins RA; Hannan RD; Papenfuss AT; Johnstone RW
Nat Commun; 2017 Mar; 8():14581. PubMed ID: 28262675
[TBL] [Abstract][Full Text] [Related]
13. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
Baxter EW; Blyth K; Cameron ER; Neil JC
J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.
Rakhra K; Bachireddy P; Zabuawala T; Zeiser R; Xu L; Kopelman A; Fan AC; Yang Q; Braunstein L; Crosby E; Ryeom S; Felsher DW
Cancer Cell; 2010 Nov; 18(5):485-98. PubMed ID: 21035406
[TBL] [Abstract][Full Text] [Related]
15. MYC synergizes with activated BRAFV600E in mouse lung tumor development by suppressing senescence.
Tabor V; Bocci M; Alikhani N; Kuiper R; Larsson LG
Cancer Res; 2014 Aug; 74(16):4222-9. PubMed ID: 24934810
[TBL] [Abstract][Full Text] [Related]
16. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.
Sharpless NE; Bardeesy N; Lee KH; Carrasco D; Castrillon DH; Aguirre AJ; Wu EA; Horner JW; DePinho RA
Nature; 2001 Sep; 413(6851):86-91. PubMed ID: 11544531
[TBL] [Abstract][Full Text] [Related]
17. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo.
Blyth K; Vaillant F; Hanlon L; Mackay N; Bell M; Jenkins A; Neil JC; Cameron ER
Cancer Res; 2006 Feb; 66(4):2195-201. PubMed ID: 16489021
[TBL] [Abstract][Full Text] [Related]
18. ARF: connecting senescence and innate immunity for clearance.
Kearney AY; Anchang B; Plevritis S; Felsher DW
Aging (Albany NY); 2015 Sep; 7(9):613-5. PubMed ID: 26412380
[TBL] [Abstract][Full Text] [Related]
19. Immortalization of mouse myogenic cells can occur without loss of p16INK4a, p19ARF, or p53 and is accelerated by inactivation of Bax.
Nowak JA; Malowitz J; Girgenrath M; Kostek CA; Kravetz AJ; Dominov JA; Miller JB
BMC Cell Biol; 2004 Jan; 5():1. PubMed ID: 14711384
[TBL] [Abstract][Full Text] [Related]
20. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]